Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Lisa Cabott Carson is Chief Financial Officer at Phio Pharmaceuticals. OQRO lists 3 transactions filed with the SEC under this name, the latest on Sep 29, 2026, each linked to the official Form 4.
Chief Financial Officer
Disclosures on record
3
Companies involved
1
As of the latest filing on , Lisa Cabott Carson reported holding 189,112 shares of Phio Pharmaceuticals (PHIO), worth about $146K at the last close of $1 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Phio Pharmaceuticals PHIO | 189,112 | 189K direct | $1 | $146K | Sep 28, 2026 |
Is this Lisa Cabott Carson’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Phio PharmaceuticalsPHIO
3 disclosures · Feb 2026 – Sep 2026
Sep 28, 2026108Kdisclosed Sep 29
DetailsOfficial recordSep 11, 202613Kdisclosed Sep 15
DetailsOfficial recordFeb 5, 202647Kdisclosed Feb 6
DetailsOfficial recordOn the latest SEC Form 4, dated Sep 28, 2026, Lisa Cabott Carson reported holding 189,112 shares of Phio Pharmaceuticals (PHIO). At the last close of $1 on Nov 13, 2026, that is about $146K. This is the stake disclosed in filings, not a net worth.